Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Rheumatology Reports
Published in: Current Rheumatology Reports 7/2018

01-07-2018 | Psoriatic Arthritis (J Scher, Section Editor)

Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review

Authors: Francesca Prignano, Veronica Rogai, Elisabetta Cavallucci, Alessandro Bitossi, Volker Hammen, Fabrizio Cantini

Published in: Current Rheumatology Reports | Issue 7/2018

Login to get access

Abstract

Purpose of Review

Understanding prevalence of diseases within specific regions of a country is important for optimal allocation of healthcare resources/funds. We performed a systematic review to obtain a clearer picture of the epidemiology of psoriasis and psoriatic arthritis across and within specific regions of Italy.

Recent Findings

Prevalence of psoriasis in specific regions showed more variability (0.8–4.5%) than that in the total population (1.8–3.1%). Prevalence of psoriatic arthritis in the general population was reported for only two regions, Chiavari (0.09%) and Marche (0.42%). All other studies reported prevalence of psoriatic arthritis in patients with psoriasis in single centres and Italy-wide (4.7–47.1%). Prevalence of psoriatic arthritis was highest in patients with nail and/or scalp psoriasis and/or intergluteal/perianal region involvement.

Summary

Based on current available data, these conditions appear to affect a substantial number of people and will likely have an important impact on the Italian healthcare system.
Literature
1.
2.
Cimmino MA. Epidemiology of psoriasis and psoriatic arthritis. Reumatismo. 2007;59(Suppl 1):19–24.PubMed
3.
Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, et al. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70(5):871–81.e1–30.CrossRefPubMed
4.
Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One. 2012;7:e52935.CrossRefPubMedPubMedCentral
5.
Christophers E, Barker JN, Griffiths CE, Daudén E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2010;24(5):548–54.CrossRefPubMed
6.
Patrizi A, Venturi M, Scorzoni R, Pazzaglia M, Malavolta N, Bardazzi F. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? G Ital Dermatol Venereol. 2014;149(2):177–84.PubMed
7.
Bonifati C, Elia F, Francesconi F, Ceralli F, Izzi S, Solivetti FM, et al. The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis. J Eur Acad Dermatol Venereol. 2012;26(5):627–33.CrossRefPubMed
8.
Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol. 2005;15(4):279–83.PubMed
9.
Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, et al. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol. 2010;20(5):593–8.PubMed
10.
Hanova P, Pavelka K, Holcatova I, Pikhart H. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol. 2010;39:310–7.CrossRefPubMed
11.
Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6.CrossRefPubMed
12.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentral
13.
De Angelis R, Salaffi F, Grassi W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol. 2007;36(1):14–21.CrossRefPubMed
14.
Salaffi F, De Angelis R, Grassi W, MArche Pain Prevalence; INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005;23(6):819–28.PubMed
15.
Sardu C, Cocco E, Mereu A, Massa R, Cuccu A, Marrosu MG, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One. 2012;7(3):e32487.CrossRefPubMedPubMedCentral
16.
Saraceno R, Mannheimer R, Chimenti S. Regional distribution of psoriasis in Italy. J Eur Acad Dermatol Venereol. 2008;22(3):324–9.CrossRefPubMed
17.
Naldi L, Colombo P, Placchesi EB, Piccitto R, Chatenoud L, La Vecchia C, et al. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology. 2004;208(1):38–42.CrossRefPubMed
18.
Cimmino MA, Zampogna A, Murroni S, Baruffi S, Alessio G, Maio T, et al. Methodology of an epidemiologic prevalence study in rheumatology: the Chiavari study [in Italian]. Reumatismo. 2002;54(1):40–7.PubMed
19.
• Dini V, Martini P, Bellini M, Bagnoni G, Marsili F, Lancia U. Psoriatic arthritis prevalence in the clinical practice of dermatologists in North-West Tuscany centres of excellence for psoriasis: a screening experience. G Ital Dermatol Venereol. 2017;152:24–7. This study provides insights into the presentation of arthritis in patients with psoriasis and differences between patients with psoriasis with and without arthritis in a clinical setting. PubMed
20.
• Piaserico S, Gisondi P, Amerio P, Amoruso G, Campanati A, Conti A, et al. Validation and field performance of the Italian version of the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire. Acta Derm Venereol. 2016;96(217):96–101. This study validates the Italian version of the Psoriatic Arthritis Screening and Evaluation questionnaire in a real-world setting across multiple dermatology clinics in Italy. PubMed
21.
De Marco G, Cattaneo A, Battafarano N, Lubrano E, Carrera CG, Marchesoni A. Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients. Arch Dermatol Res. 2012;304(9):719–26.CrossRefPubMed
22.
Altobelli E, Maccarone M, Petrocelli R, Marziliano C, Giannetti A, Peris K, et al. Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population. BMC Public Health. 2007;7:59.CrossRefPubMedPubMedCentral
23.
Finzi AF, Benelli C. A clinical survey of psoriasis in Italy: 1st AISP report. Interdisciplinary Association for the Study of Psoriasis. J Eur Acad Dermatol Venereol. 1998;10(2):125–9.CrossRefPubMed
24.
Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W, et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol. 1995;22(8):1499–503.PubMed
25.
De Marco G, Cattaneo A, Carrera CG, Gibertini P, Battafarano N, Marchesoni A. The EPIPSOFIRE project: a preliminary report. Drug Dev Res. 2014;75(Suppl 1):S85–7.CrossRefPubMed
26.
Tinazzi I, Adami S, Zanolin EM, Caimmi C, Confente S, Girolomoni G, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford). 2012;51(11):2058–63.CrossRef
27.
Cervini C, Leardini G, Mathieu A, Punzi L, Scarpa R. Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 Italian patients [in Italian]. Reumatismo. 2005;57(4):283–90.PubMed
28.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.CrossRefPubMed
29.
Parisi R, Symmons DP, Griffiths CE, Ashcroft DM, Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.CrossRefPubMed
Metadata
Title
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review
Authors
Francesca Prignano
Veronica Rogai
Elisabetta Cavallucci
Alessandro Bitossi
Volker Hammen
Fabrizio Cantini
Publication date
01-07-2018
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 7/2018
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-018-0753-1

Other articles of this Issue 7/2018

Current Rheumatology Reports 7/2018 Go to the issue

Systemic Lupus Erythematosus (G Tsokos, Section Editor)

Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment

Psoriatic Arthritis (J Scher, Section Editor)

Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?

Vasculitis (L Espinoza, Section Editor)

CNS Vasculitis: an Approach to Differential Diagnosis and Management

Pediatric Rheumatology (S Ozen, Section Editor)

An Update on Autoinflammatory Diseases: Relopathies

Rheumatoid Arthritis (L Moreland, Section Editor)

Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis

Pediatric Rheumatology (S Ozen, Section Editor)

An Update on Autoinflammatory Diseases: Interferonopathies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits